Prognostic significance of Ape1/Ref-1 subcellular localization in non-small cell lung carcinomas

被引:0
作者
Puglisi, F
Aprile, G
Minisini, AM
Barbone, F
Cataldi, P
Tell, GN
Kelley, MR
Damante, G
Beltrami, CA
Di Loreto, C
机构
[1] Univ Udine, Policlin Udine, Clin Oncol, Chair Clin Oncol, I-33100 Udine, Italy
[2] Univ Udine, Chair Hyg, I-33100 Udine, Italy
[3] Univ Udine, Chair Anat Pathol, I-33100 Udine, Italy
[4] Univ Udine, Chair Genet, I-33100 Udine, Italy
[5] Univ Trieste, Dept Biochem Biophys & Macromol Chem, I-34127 Trieste, Italy
[6] Indiana Univ, Sch Med, Dept Pediat, Herman B Wells Ctr Pediat Res, Indianapolis, IN 46202 USA
关键词
DNA repair; non-small cell lung cancer; immunohistochemistry; prognosis; multivariate analysis; Ape1/ref-1;
D O I
暂无
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Purpose: To evaluate the prognostic value of the DNA repair/redox- protein Ape1/ref-1 in a retrospective series of consecutive non-small cell lung carcinomas (NSCLC). Patients and Methods: Sections from 91 radically resected NSCLC were analyzed for immunohistochemical expression of Ape1/ref-1. For each case 1,000 tumor cells were evaluated to detect nuclear and cytoplasmic reactivity scored as a percentage of positive cells. With respect to sub-cellular localization and percentage of immunoreactive cells, each tumor was classified as "cytoplasmic" or "non cytoplasmic". The survival rate according to Ape1/ref-1 sub-cellular localization was calculated. Results: The main pattern of Ape1/ref-1 expression was nuclear. No significant difference was observed in Ape1/ref-1 pattern according to histotype (squamous vs adenocarcinoma). Among adenocarcinomas, a cytoplasmic expression of Ape1/ref-1 was significantly associated with poor survival rate in univariate (p=0.01) and multivariate (p=0.07) analyses. In addition, a cytoplasmic expression of the DNA repair protein was also predictive of worse prognosis (log-rank test, p=0.02) in cases with lymph node involvement, regardless of histotype. Conclusion: The results suggest a potential role of Ape1/ref-1 sub-cellular localization as a prognostic indicator in patients with NSCLC In particular, cytoplasmic localization of the protein seems to confer a poor outcome in subgroups of patients with nodal involvement or adenocarcinoma histotype.
引用
收藏
页码:4041 / 4049
页数:9
相关论文
共 39 条
[1]   THE ARABIDOPSIS-THALIANA APURINIC ENDONUCLEASE ARP REDUCES HUMAN TRANSCRIPTION FACTORS FOS AND JUN [J].
BABIYCHUK, E ;
KUSHNIR, S ;
VANMONTAGU, M ;
INZE, D .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1994, 91 (08) :3299-3303
[2]  
COX DR, 1972, J R STAT SOC B, V34, P187
[3]   TTF-I gene expression in human lung tumours [J].
Fabbro, D ;
DiLoreto, C ;
Stamerra, O ;
Beltrami, CA ;
Lonigro, R ;
Damante, G .
EUROPEAN JOURNAL OF CANCER, 1996, 32A (03) :512-517
[4]   Phosphorylation of the DNA repair protein APE/REF-1 by CKII affects redox regulation of AP-1 [J].
Fritz, G ;
Kaina, B .
ONCOGENE, 1999, 18 (04) :1033-1040
[5]   Cancer statistics, 2001 [J].
Greenlee, RT ;
Hill-Harmon, MB ;
Murray, T ;
Thun, M .
CA-A CANCER JOURNAL FOR CLINICIANS, 2001, 51 (01) :15-36
[6]   Requirement for human AP endonuclease 1 for repair of 3′-blocking damage at DNA single-strand breaks induced by reactive oxygen species [J].
Izumi, T ;
Hazra, TK ;
Boldogh, I ;
Tomkinson, AE ;
Park, MS ;
Ikeda, S ;
Mitra, S .
CARCINOGENESIS, 2000, 21 (07) :1329-1334
[7]   Regulation of protein transport to the nucleus: Central role of phosphorylation [J].
Jans, DA ;
Hubner, S .
PHYSIOLOGICAL REVIEWS, 1996, 76 (03) :651-685
[8]   Identification of redox/repair protein Ref-1 as a potent activator of p53 [J].
Jayaraman, L ;
Murthy, KGK ;
Zhu, C ;
Curran, T ;
Xanthoudakis, S ;
Prives, C .
GENES & DEVELOPMENT, 1997, 11 (05) :558-570
[9]   Human AP endonuclease 1 (HAP1) protein expression in breast cancer correlates with lymph node status and angiogenesis [J].
Kakolyris, S ;
Kaklamanis, L ;
Engels, K ;
Fox, SB ;
Taylor, M ;
Hickson, ID ;
Gatter, KC ;
Harris, AL .
BRITISH JOURNAL OF CANCER, 1998, 77 (07) :1169-1173
[10]  
Kakolyris S, 1999, J PATHOL, V189, P351, DOI 10.1002/(SICI)1096-9896(199911)189:3<351::AID-PATH435>3.0.CO